1.Clinical Study of Neonatal Group B beta-hemolytic Streptococcal Meningitis: 10 Years Experience.
Do gyeong SEUNG ; Yoo Jong WON ; Seung taek YOO ; Yeon kyun OH
Korean Journal of Perinatology 2005;16(3):222-229
OBJECTIVE: Most common organism of bacterial meningitis was E.coli in the past. However, it is changed to group B beta-hemolytic streptococcus (GBS) recently. Incidence of neonatal GBS meningitis is still not reported in Korea, but sporadic cases were reported continuously. So, we investigated the exact incidence of neonatal GBS meningitis for 10 years including other clinical manifestations for it's diagnosis and treatment. METHODS: We analyzed 9 cases with chart review retrospectively who had been admitted to the pediatric ward or NICU in Wonkwang University Hospital from July 1994 to June 2004. They had proven neonatal GBS meningitis with culture or latex agglutination test in CSF. RESULTS: Incidence of disease was 0.79 with 0.09 in early onset and 0.7 in late onset type per 1,000 live births. Sex ratio was not different, and nearly all 8 cases (88.9%) were fullterm and late onset type. The associated obstetric factors were noted in 5 cases (55.6%), and c-section of 3 cases (33.3%) was most common factor. In clinical features, fever was seen in all cases, and lethargy and poor feeding in nearly all cases (88.9%), and irritability (55.6%), bulging fontanelle and convulsion (44.4%) were seen. There were abnormal findings in 7 cases (77.7%) <1.0 in CBC differential ratio and 8 cases (88.9%) >CRP 5 mg/dL in peripheral blood exams on admission. There were abnormal CSF findings which were increased wbc of 5 cases (55.6%, > or =1,000/mm3), neutrophil of 8 cases (88.9%), protein of 8 cases (88.9%, >200 mg/dL) and CRP of 6 cases (66.7%, 3 mg/dL), and decreased sugar of 6 cases (66.7%, <45 mg/dL) and severely decreased of 4 cases (44.4%, <20 mg/dL). There were abnormal brain CT findings in 6 cases (66.7%) such as cerebral infarction, subdural effusion, hydrocephalus, and intracranial hemorrhage. Eight cases (88.9%) were alive, and mean duration of therapy was 26.1+/-9.9 days. CONCLUSION: Although the incidence of GBS is not high, it is reported to be an important organism in neonatal bacterial meningitis. So, we recommend early detection and active treatment for neonatal GBS meningitis to prevent severe complication and prolonged therapy.
Brain
;
Cerebral Infarction
;
Diagnosis
;
Fever
;
Hydrocephalus
;
Incidence
;
Intracranial Hemorrhages
;
Korea
;
Latex Fixation Tests
;
Lethargy
;
Live Birth
;
Meningitis*
;
Meningitis, Bacterial
;
Neutrophils
;
Retrospective Studies
;
Seizures
;
Sex Ratio
;
Streptococcus
;
Subdural Effusion
2.Cost-Minimization Analysis of Biologic Disease-Modifying Antirheumatic Drugs Administered by Subcutaneous Injections in Patients with Rheumatoid Arthritis.
Seung Hoo PARK ; Min Young LEE ; Eui Kyung LEE
Korean Journal of Clinical Pharmacy 2016;26(1):59-69
BACKGROUND: The subcutaneous formulation of biologic disease-modifying antirheumatic drugs (DMARDs) was preferred due to favored self-administration and would be an economical treatment option for patients with rheumatoid arthritis. This study was to compare the economic impact of biologic DMARDs administered by subcutaneous injection in patients with rheumatoid arthritis who had inadequate response to conventional DMARDs. METHODS: The cost-minimization analysis was conducted to estimate the lifetime health care costs of treatment sequences with subcutaneous biologic DMARDs as first-line therapy from a health care system perspective. The Markov model was developed to represent the transitions through treatment sequences based on American College of Rheumatology response rate and discontinuation rate. The health care costs comprised the cost of medications, administration, dispensing, outpatient visits, test/diagnostic examination, palliative therapy and treatment of serious infection. All costs were expressed in 2016 Korean Won (KRW) and discounted at 5%. RESULTS: The mean lifetime health care cost per patient was lowest in the etanercept sequence, which was estimated at KRW 63,441,679. The incremental costs of the treatment sequence started with adalimumab, golimumab, abatacept, and tocilizumab were KRW 7,985,730, KRW 4,064,669, KRW 2,869,947, and KRW 4,282,833, respectively, relative to etanercept sequence. These differences in costs mainly were attributable to medication costs. One-way and probabilistic sensitivity analyses confirmed that etanercept represented the option with the lowest cost compared with comparators. CONCLUSION: This study found that etanercept is likely a cost-saving treatment option among subcutaneous biologic DMARDs in patients with rheumatoid arthritis.
Antirheumatic Agents*
;
Arthritis, Rheumatoid*
;
Delivery of Health Care
;
Health Care Costs
;
Humans
;
Injections, Subcutaneous*
;
Outpatients
;
Palliative Care
;
Rheumatology
;
Abatacept
;
Adalimumab
;
Etanercept
3.Uterine Serous Adenocarcinoma in an Elderly Postmenopausal Woman: Clinically Misdiagnosed as Uterine Cervix Cancer.
Jeong A HONG ; Tae Hee KIM ; Hae Hyeog LEE ; Soo Ho CHUNG ; Gyeong Eun HEO ; Dong Su JEON ; Jeong Ja KWAK ; Seung Do CHOI ; Eunkyung HAN
Journal of Menopausal Medicine 2015;21(3):171-174
Uterine serous adenocarcinoma (USC) is rare and invasive cancer. This cancer is more often reported in the ovary, the fallopian tube, and the endometrium than uterine cervix. No matter where the tumor is located, the tumor exhibits similar histological characteristics. So when uterine cancer is proven to be serous adenocarcinoma, it is necessary to see if the tumor originated from ovary or endometrium and invaded the cervix. We report a case of a 73-year-old postmenopausal woman with USC arising near the internal os of endocervical canal, clinically misdiagnosed as uterine cervix cancer.
Adenocarcinoma*
;
Aged*
;
Cervix Uteri*
;
Endometrium
;
Fallopian Tubes
;
Female
;
Humans
;
Ovary
;
Uterine Cervical Neoplasms
;
Uterine Neoplasms
;
Uterus
4.Clinical Effectiveness of Diagnosis Using Immunohistochemistry and New Grade in Gastrointestinal Stromal Tumors (GISTs).
Chae Young LEE ; Jin Cho KIM ; Won Woo KIM ; Hyung Min CHIN ; Wook KIM ; Cho Hyun PARK ; Hae Myung JEON ; Seung Man PARK ; Keun Woo LIM ; Woo Bae PARK ; Seung Nam KIM ; Gyo Young LEE ; Gyeong Sin PARK ; Do Young SONG ; Jong Ho JOO
Journal of the Korean Surgical Society 2003;64(6):471-479
PURPOSE: Paraffin-embedded tissue samples from the gastrointestinal tract, which had been diagnosed as tumors of a mesenchymal origin, were reviewed by an immunohistochemical staining method. The prognostic significances of the immunohistochemical subtypes and anatomical locations were also investigated. GIST, as a new grading system, was compared with the pre-existing system for its useful prognostic significance. METHODS: 122 cases were evaluated and classified by immunohistochemical staining for KIT, CD34, actin, desmin, vimentin, S-100 protein and NSE. RESULTS: Positivity for both KIT and CD34 of 92.6 and 73.8%, respectively, indicated that KIT was more effective for the diagnosis of GISTs. The stomach (62.3%) and small bowel (23.7%) were most common organs of GIST. There was no difference in the prognosis between these two organs. Immunophenotypically, the uncommitted, myoid, combined and neural types were 37.7, 23.7, 20.2 and 7%, respectively. There was no significant difference in the prognosis between these types. The old grading system showed no difference between the borderline and malignant groups (P=0.14), whereas, the new grading system showed a significant difference between the intermediate and high risk groups (P=0.01). CONCLUSION: KIT is more useful for the diagnosis of GOSTs. The immunophenotypical classification and anatomical location showed no prognostic significance in GISTs. Therefore, the new grading system might be more useful than older system.
Actins
;
Classification
;
Desmin
;
Diagnosis*
;
Gastrointestinal Stromal Tumors*
;
Gastrointestinal Tract
;
Immunohistochemistry*
;
Prognosis
;
S100 Proteins
;
Stomach
;
Vimentin
5.SARS‑CoV‑2 Omicron variant causes brain infection with lymphoid depletion in a mouse COVID‑19 model
Na Yun LEE ; Youn Woo LEE ; Seung‑Min HONG ; Dain ON ; Gyeong Min YOON ; See‑He AN ; Ki Taek NAM ; Jun‑Young SEO ; Jeon‑Soo SHIN ; Yang‑Kyu CHOI ; Seung Hyun OH ; Jun‑Won YUN ; Ho Young LEE ; Kang‑Seuk CHOI ; Je Kyung SEONG ; Jun Won PARK
Laboratory Animal Research 2023;39(2):165-171
Background:
The Omicron variant has become the most prevalent SARS-CoV-2 variant. Omicron is known to induce milder lesions compared to the original Wuhan strain. Fatal infection of the Wuhan strain into the brain has been well documented in COVID-19 mouse models and human COVID-19 cases, but apparent infections into the brain by Omicron have not been reported in human adult cases or animal models. In this study, we investigated whether Omicron could spread to the brain using K18-hACE2 mice susceptible to SARS-CoV-2 infection.
Results:
K18-hACE2 mice were intranasally infected with 1 × 105 PFU of the original Wuhan strain and the Omicron variant of SARS-CoV-2. A follow-up was conducted 7 days post infection. All Wuhan-infected mice showed > 20% body weight loss, defined as the lethal condition, whereas two out of five Omicron-infected mice (40%) lost > 20% body weight. Histopathological analysis based on H&E staining revealed inflammatory responses in the brains of these two Omicron-infected mice. Immunostaining analysis of viral nucleocapsid protein revealed severe infection of neuron cells in the brains of these two Omicron-infected mice. Lymphoid depletion and apoptosis were observed in the spleen of Omicron-infected mice with brain infection.
Conclusion
Lethal conditions, such as severe body weight loss and encephalopathy, can occur in Omicron-infected K18-hACE2 mice. Our study reports, for the first time, that Omicron can induce brain infection with lymphoid depletion in the mouse COVID-19 model.
6.Standardized Pathology Report for Colorectal Cancer, 2nd Edition
Baek-hui KIM ; Joon Mee KIM ; Gyeong Hoon KANG ; Hee Jin CHANG ; Dong Wook KANG ; Jung Ho KIM ; Jeong Mo BAE ; An Na SEO ; Ho Sung PARK ; Yun Kyung KANG ; Kyung-Hwa LEE ; Mee Yon CHO ; In-Gu DO ; Hye Seung LEE ; Hee Kyung CHANG ; Do Youn PARK ; Hyo Jeong KANG ; Jin Hee SOHN ; Mee Soo CHANG ; Eun Sun JUNG ; So-Young JIN ; Eunsil YU ; Hye Seung HAN ; Youn Wha KIM ;
Journal of Pathology and Translational Medicine 2020;54(1):1-19
The first edition of the ‘Standardized Pathology Report for Colorectal Cancer,’ which was developed by the Gastrointestinal Pathology Study Group (GIP) of the Korean Society of Pathologists, was published 13 years ago. Meanwhile, there have been many changes in the pathologic diagnosis of colorectal cancer (CRC), pathologic findings included in the pathology report, and immunohistochemical and molecular pathology required for the diagnosis and treatment of colorectal cancer. In order to reflect these changes, we (GIP) decided to make the second edition of the report. The purpose of this standardized pathology report is to provide a practical protocol for Korean pathologists, which could help diagnose and treat CRC patients. This report consists of “standard data elements” and “conditional data elements.” Basic pathologic findings and parts necessary for prognostication of CRC patients are classified as “standard data elements,” while other prognostic factors and factors related to adjuvant therapy are classified as “conditional data elements” so that each institution could select the contents according to the characteristics of the institution. The Korean version is also provided separately so that Korean pathologists can easily understand and use this report. We hope that this report will be helpful in the daily practice of CRC diagnosis.
7.Electroporation of AsCpf1/RNP at the Zygote Stage is an Efficient Genome Editing Method to Generate Knock-Out Mice Deficient in Leukemia Inhibitory Factor
Yeon Sun KIM ; Gyeong Ryeong KIM ; Mira PARK ; Seung Chel YANG ; So Hee PARK ; Ji Eun WON ; Ju Hee LEE ; Ha Eun SHIN ; Haengseok SONG ; Hye-Ryun KIM
Tissue Engineering and Regenerative Medicine 2020;17(1):45-53
METHODS:
The efficiency of electroporation-based delivery of AsCpf1/mRNA and AsCpf1/RNP to target exon 3 of leukemia inhibitory factor (Lif) into mouse zygotes was evaluated. Embryos that developed to the two-cell stage after zygote electroporation were transferred into the oviducts of surrogate mothers to produce AsCpf1-mediated LIF KO mice. The genome editing efficiency of blastocysts and pups was tested using the T7E1 assay and/or DNA sequencing. Congenital abnormalities and reproductive phenotypes in LIF KO mice produced by electroporation with AsCpf1/RNP were examined.
RESULTS:
Survival and two-cell development of electroporated zygotes were comparable between the AsCpf1/mRNA and AsCpf1/RNP groups, whereas genome editing efficiency was relatively higher in the AsCpf1/RNP group (13.3% vs 18.1% at blastocyst and 33.3% vs 45.5% at offspring), respectively. Two mouse lines with a frameshift mutation in exon 3 of the Lif gene were established from the AsCpf1/RNP group. All congenital abnormalities of LIF KO mice produced by AsCpf1/RNP electroporation were observed. AsCpf1-mediated LIF KO mice showed postnatal growth retardation and implantation failure, both of which are major phenotypes of LIF KO mice generated by conventional gene targeting.
CONCLUSION
Electroporation of AsCpf1/RNP at the zygote stage is an efficient genome editing method to produce KO mice.
8.Electroporation of AsCpf1/RNP at the Zygote Stage is an Efficient Genome Editing Method to Generate Knock-Out Mice Deficient in Leukemia Inhibitory Factor
Yeon Sun KIM ; Gyeong Ryeong KIM ; Mira PARK ; Seung Chel YANG ; So Hee PARK ; Ji Eun WON ; Ju Hee LEE ; Ha Eun SHIN ; Haengseok SONG ; Hye-Ryun KIM
Tissue Engineering and Regenerative Medicine 2020;17(1):45-53
METHODS:
The efficiency of electroporation-based delivery of AsCpf1/mRNA and AsCpf1/RNP to target exon 3 of leukemia inhibitory factor (Lif) into mouse zygotes was evaluated. Embryos that developed to the two-cell stage after zygote electroporation were transferred into the oviducts of surrogate mothers to produce AsCpf1-mediated LIF KO mice. The genome editing efficiency of blastocysts and pups was tested using the T7E1 assay and/or DNA sequencing. Congenital abnormalities and reproductive phenotypes in LIF KO mice produced by electroporation with AsCpf1/RNP were examined.
RESULTS:
Survival and two-cell development of electroporated zygotes were comparable between the AsCpf1/mRNA and AsCpf1/RNP groups, whereas genome editing efficiency was relatively higher in the AsCpf1/RNP group (13.3% vs 18.1% at blastocyst and 33.3% vs 45.5% at offspring), respectively. Two mouse lines with a frameshift mutation in exon 3 of the Lif gene were established from the AsCpf1/RNP group. All congenital abnormalities of LIF KO mice produced by AsCpf1/RNP electroporation were observed. AsCpf1-mediated LIF KO mice showed postnatal growth retardation and implantation failure, both of which are major phenotypes of LIF KO mice generated by conventional gene targeting.
CONCLUSION
Electroporation of AsCpf1/RNP at the zygote stage is an efficient genome editing method to produce KO mice.